Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4481)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 15, 2023 (publication date) through Apr 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin C, Li ZL, Cai XL, Hu SY, Lv F, Yang WJ, Ji LN. Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis. World J Diabetes 2023; 14(10): 1573-1584 [PMID: 37970134 DOI: 10.4239/wjd.v14.i10.1573] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i10/1573.htm |
| Number | Citing Articles |
| 1 |
Kotha Sugunakar Reddy, Archana Gaur, Sakthivadivel Varatharajan, Arvind Kumar Morya. Chiglitazar and Thiazolidinedione in patients with type 2 diabetes: Which is better?. World Journal of Diabetes 2024; 15(3): 565-567 doi: 10.4239/wjd.v15.i3.565
Abstract(416) |
Core Tip(455) |
Full Article(HTML)(999)
|
Full Article with Cover (PDF)-714K(108)
|
Full Article (Word)-35K(0)
|
Audio-1539K(4)
|
Peer-Review Report-219K(36)
|
Answering Reviewers-49K(41)
|
Full Article (PDF)-329K(116)
|
Full Article (XML)-21K(41)
|
Times Cited (0)
|
Total Visits (2867)
|
Open
|
| 2 |
Zhouling Xie, Jiwei Xin, Chuping Huang, Chenzhong Liao. Drugs targeting peroxisome proliferator-activated receptors. Drug Discovery Today 2025; 30(3): 104318 doi: 10.1016/j.drudis.2025.104318
|
| 3 |
Sujun Xiao, Mingxu Qi, Qinyi Zhou, Huiqin Gong, Duhui Wei, Guangneng Wang, Qilun Feng, Zhou Wang, Zhe Liu, Yiren Zhou, Xiaofeng Ma. Macrophage fatty acid oxidation in atherosclerosis. Biomedicine & Pharmacotherapy 2024; 170: 116092 doi: 10.1016/j.biopha.2023.116092
|
| 4 |
Wenxuan Li, Yangang Wang, Chuanfeng Liu, Yongzhuo Yu, Lili Xu, Bingzi Dong. Evaluation of the Regulatory Effect of the Pan-PPAR Agonist Chiglitazar on the Dawn Phenomenon. Diabetes Therapy 2025; 16(4): 731 doi: 10.1007/s13300-025-01708-9
|